6
Oct
2026

GM Pharmaceuticals

Exhibitor at CPHI Milan 2026 stand 20F19, Finished Dosage & Formulation
About Us

GM PHARMA is an international pharmaceutical company with medicines & FS manufactured in GMP-certified manufacturing plants in Western EU countries and in its ow GMP-certified manufacturing plant in Georgia. GM Pharma's solid dosage forms manufacturing site in Tbilisi, Georgia, is the largest pharmaceutical plant in the Caucasus region. Company employs more than 600 professionals including those employed in its export countries. With >140 brands and >230 dosage forms in its portfolio, GM Pharma holds one of the broadest product portfolio in the region.

  • Country/Region:
    Georgia
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20F19, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Micoflu

    Product Micoflu

    Fluconazole
  • Trimecor Mr

    Product Trimecor Mr

    Trimetazidine
  • Turbomicron G

    Product Turbomicron G

    Diosmin / Hesperidin Purified Micronized Fractions
  • Azimac

    Product Azimac

    Azithromycin
  • Lacto G Forte

    Product Lacto G Forte

    3 Bifidumbacterium, Lactobacillus, FOS

GM Pharmaceuticals Resources (1)